Human Fetus in the Womb at 25 Weeks (Black Skin)

Description

The fetus lies in a flexed attitude within the amniotic cavity, surrounded by the translucent membranes of the amniotic sac and enclosed by the vascularised uterine wall. Seen from the left side, the head is deviated toward the upper left with eyelids still fused-looking and closed, the upper limb raised so the open fetal hand displays fully separated fingers, and the lower limbs drawn up with the feet and toes clearly modelled. The umbilicus is visible on the anterior abdominal wall, where the umbilical cord inserts and spirals in a helical course, its paired umbilical arteries and single umbilical vein distinguishable through the cord sheath as it runs to a discoid placenta shown in section along the uterine lining. Subcutaneous fat is still sparse, giving the skin a thin, reddish, translucent quality characteristic of the second half of the second trimester. Week 25 sits at the threshold of extrauterine viability, when pulmonary development enters the saccular stage and surfactant production begins, making gestational-age landmarks central to counselling in threatened preterm birth. The depicted cord and placental relationship underpins routine obstetric assessment: cord insertion site, vessel number, and placental position are checked at anatomy and growth ultrasound, while Doppler interrogation of the umbilical artery is used to evaluate placental function in suspected fetal growth restriction. Amniotic fluid volume, membrane integrity, and fetal lie as shown here are the same parameters documented in biophysical profile scoring. Suited to obstetric and midwifery teaching sequences on trimester-by-trimester development, embryology and neonatology lectures, and prenatal atlas plates where a consistent series of gestational weeks is required. The realistic rendering also serves antenatal class handouts, patient education on fetal growth and viability, and editorial or publication figures for pregnancy and perinatal medicine. Anatomical accuracy verified by SciePro's Medical Advisory Board.